horizon grammatica icon icon map search arrow rss twitter facebook apply twitter facebook rss

B-PHARM Pharmaceutical Company located in Russia will launch the production of liquid medical products in the Kaluga Region

On July 03, the Government of the Kaluga Region and B-Pharm Production have signed the agreement on construction of the plant to produce liquid medical products on the territory of Vorsino Industrial Park. The correspondent document was executed by Vladislav Shapsha, Acting Governor of the Kaluga Region and Valery Ivashinenko, Director General of the Company.

B-PHARM Pharmaceutical Company is an innovative and actively developing pharmaceutical company, whose primary activities are the development, registration, production and promotion of its own medical products, as well as the supply of modern and effective medicines to the hospital sector and pharmacy chains of the Russian Federation and other countries.

The Company's main goal is to bring innovative medical products and medical devices to the Russian market by means of interaction with major pharmaceutical companies, active work in the patent and certification fields, as well as in the field of high-quality analytical researches.

The actual volume of investments to the project implementation will amount more than 400 mln RUB and the number of new jobs will be about 35. The object commissioning is scheduled for December 2020, while the production will start by the end of 2021.

Vladislav Shapsha noted that the pharmaceutical cluster is one of the leading in the region. "It is very important that our partners have shown interest in organizing production in the Kaluga Region," added the Head of the Region.

In turn, Valery Ivashinenko, the Company's Director General announced plans to localize production within the territory of the Kaluga Region.